 |
|
 |
STAFF & DIRECTORS of Cell Therapies
Cell Therapies, through the Centre for Blood Cell Therapy combines leading scientists and researchers, along with state-of-the-art equipment. The staff of CT | Dr Dominic Wall is the Production Manager for the Centre for Blood Cell Therapies (CBCT) and is the production nominee cited for the purposes of licensing by the Therapeutics Good Administration. Ray is the Managing Director of Cell Therapies Pty Ltd the commercial entity specifically created to capture the value inherent in Peter Mac's Center for Blood Cell Therapies. |
MBBS (Hons) MD MRACMA FRACP FRCPA
Professor Miles Prince is the Director of the Centre for Blood Cell Therapies at Peter MacCallum Cancer Centre, Melbourne, Australia and Director of the Blood and Marrow Transplant Service..
Professor Miles Prince is also appointed as haematologist at St Vincent’s, Royal Melbourne Hospitals, Australian Red Cross Blood Service and Cabrini Hospital Department of Oncology. He is a Professor of Medicine at both University of Melbourne and Monash University .
Professor Prince is qualified as a clinician (Fellow of the Royal Australasian College of Physicians) and pathologist (Fellow of the Royal College of Pathologists of Australasia). He was awarded his research degree (Doctor of Medicine, Monash University) in 1998. He is a member of the American, Australian and European Societies of Haematology and Oncology.
Professor Prince graduated from Monash University in 1986 and undertook physicians training at the Alfred and Austin Hospitals in Melbourne and completed his laboratory haematology training at the Royal Prince Alfred Hospital, Sydney. Prof Prince subsequently spent three years in Toronto, Canada examining laboratory research aspects of gene therapy in myeloma and gene transfer into blood stem cells.
During his time in Toronto, Miles Prince also completed a clinical fellowship in transplantation and was awarded the prestigious Edward Christie Stevens Fellowship in Medicine and the Postgraduate Fellowship Award for his work in multiple myeloma. Since returning to Australia in 1996, has been Head of Haematology at Peter Mac.
His clinical expertise is malignant haematology - including lymphoma, leukaemia, myelodysplasia, myeloproliferative disorders, myeloma and stem cell transplantation for both haematological malignancies and solid tumours. The clinical stem cell program is closely linked to the Peter Mac Stem Cell laboratories which has research groups involved in blood, skin, neural, mesenchymal, gut ADULT stem cells and stem cell plasticity. A number of clinical trials are being ‘translated’ from the laboratory research work. Most recently he has developed clinical trials for expansion of blood stem cells and immunotherapy for a variety of tumours through the Cancer Immunology research program at Peter Mac. .
He also has major interests and expertise in blood clotting and bleeding disorders and transfusion medicine. He has an international reputation for his clinical and basic research work, teaching of undergraduate, postgraduate and specialists. He has published over 200 manuscripts and is on academic and industry editorial and advisory boards.
